Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
Although statins have served as the cornerstone for pharmacological lowering of lipid levels in atherosclerotic cardiovascular disease (ASCVD) risk reduction, many patients are unable to achieve target doses of statin medication due to side effects or target levels of cholesterol reduction on statin...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2024-03-01
|
| Серии: | Pharmacoepidemiology |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/2813-0618/3/1/9 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|